This case explores maximizing shareholder value as a goal in executive decision making. Over a period of nine years, three different Pfizer CEOs make critical decisions intended to increase shareholder value. But the results are disappointing. To allow st

【書誌情報】

ページ数：19ページ

サイズ：A4

商品番号：HBSP-110003

発行日：2009/7/7

登録日：2010/7/12